For a copy of this research report please contact your CLSA advisor.
October 16th 2021
October 13th 2021
October 12th 2021
October 4th 2021
September 29th 2021
September 28th 2021
It takes a great deal of passion to pursue the fight against cancer and autoimmune diseases. We put our heart and soul into winning it.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
Accurate research and development is the strongest foundation for developing effective treatments.
What is LAG-3?
Lymphocyte-activation gene 3, or LAG-3 (LAG-3), is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T cell function.
LAG-3 is being used for many immunotherapy treatments including Eftilagimod Alpha from Immutep.